Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDerwent London Regulatory News (DLN)

Share Price Information for Derwent London (DLN)

Share Price is delayed by 15 minutes
Get Live Data
1,765.00    -13.00 (-0.73%)
Bid:
1,768.00
Ask:
1,771.00
Spread: 3.00 (0.17%)
Market Cap: £1.98b
DLN Live PriceLast checked at - London Stock Exchange

Intraday Derwent London Share Chart

Director/PDMR Shareholding

4 Apr 2023 15:30

RNS Number : 3470V
Derwent London PLC
04 April 2023
 

For immediate release

 

 

Derwent London plc ("Derwent London"/"the Company")

 

Notification of interests of Directors and Persons DischargingManagerial Responsibility ("PDMR")

 

 

The Company announces the following changes to the interests of Directors in the Company's ordinary shares of 5p each ('Shares').

 

Bonus deferral

 

On 4 April 2023, the Company granted the following Share-based Awards under the Derwent London Annual Bonus Plan ('the Plan'), in respect of the deferred element of the 2022 annual bonus.

 

Name

Role

Deferred Bonus Award

(Number)

Paul M Williams

Chief Executive Officer

6,570

Damian M A Wisniewski

Chief Financial Officer

5,256

Nigel Q George

Director

5,256

Emily J Prideaux

Director

4,690

 

In accordance with the Plan, bonuses of up to 100% of base salary are paid as cash. Amounts in excess of 100% are deferred into shares and released after three years (on the third anniversary of the Award's grant date), but only to the extent that the participant is still employed by Derwent London at that time. The Directors are each entitled to additional vesting shares for dividend equivalents in respect of dividends paid on vested shares between the grant date and the release date.

 

Other than the application of a percentage of the annual bonus in the acquisition of the Shares, no consideration is payable on the grant or release of an Award.

 

This announcement is made in accordance with Market Abuse Regulations and Rule 3.1 of the Disclosure and Transparency Rules.

 

The Company was notified of the grant of all Awards on 4 April 2023.

 

 

Enquiries:

D A Lawler

Company Secretary

 

4 April 2023

 

020 7659 3000

www.derwentlondon.com

 

 

The information set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.

 

1.

Details the person discharging managerial responsibilities / person closely associated

a)

Name

Paul M Williams

2.

Reason for the notification

a)

Position / status

Chief Executive Officer

b)

Initial notification / Amendment

Initial notification

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

 Derwent London plc

b)

LEI

 213800BXKQ9KZNUR1M61

4.

Details of the transaction (s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

 

5p Ordinary shares in Derwent London plc

 

GB0002652740

b)

Nature of the transaction

Grant of a conditional award under the Derwent London Annual Bonus Plan

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

23.70

6,570

 

 

d)

Aggregated information

- Aggregated volume

- Price

 

Not applicable - single transaction

e)

Date of the transaction

4 April 2023

f)

Place of the transaction

London Stock Exchange - Main Market (XLON)

 

 

1.

Details the person discharging managerial responsibilities / person closely associated

a)

Name

Damian M A Wisniewski

2.

Reason for the notification

a)

Position / status

Chief Financial Officer

b)

Initial notification / Amendment

Initial notification

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

 Derwent London plc

b)

LEI

 213800BXKQ9KZNUR1M61

4.

Details of the transaction (s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

 

5p Ordinary shares in Derwent London plc

 

GB0002652740

b)

Nature of the transaction

Grant of a conditional award under the Derwent London Annual Bonus Plan

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

23.70

5,256

 

 

 

d)

Aggregated information

- Aggregated volume

- Price

 

Not applicable - single transaction

e)

Date of the transaction

4 April 2023

f)

Place of the transaction

London Stock Exchange - Main Market (XLON)

 

 

1.

Details the person discharging managerial responsibilities / person closely associated

a)

Name

Nigel Q George

2.

Reason for the notification

a)

Position / status

Director

b)

Initial notification / Amendment

Initial notification

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

 Derwent London plc

b)

LEI

 213800BXKQ9KZNUR1M61

4.

Details of the transaction (s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

 

5p Ordinary shares in Derwent London plc

 

GB0002652740

b)

Nature of the transaction

Grant of a conditional award under the Derwent London Annual Bonus Plan

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

23.70

5,256

 

 

d)

Aggregated information

- Aggregated volume

- Price

 

Not applicable - single transaction

e)

Date of the transaction

4 April 2023

f)

Place of the transaction

London Stock Exchange - Main Market (XLON)

 

1.

Details the person discharging managerial responsibilities / person closely associated

a)

Name

Emily J Prideaux

2.

Reason for the notification

a)

Position / status

Director

b)

Initial notification / Amendment

Initial notification

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

 Derwent London plc

b)

LEI

 213800BXKQ9KZNUR1M61

4.

Details of the transaction (s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

 

5p Ordinary shares in Derwent London plc

 

GB0002652740

b)

Nature of the transaction

Grant of a conditional award under the Derwent London Annual Bonus Plan

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

23.70

4,690

 

 

d)

Aggregated information

- Aggregated volume

- Price

 

Not applicable - single transaction

e)

Date of the transaction

4 April 2023

f)

Place of the transaction

London Stock Exchange - Main Market (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFILSFISIIV
Date   Source Headline
2nd Jun 20262:00 pmRNSHolding(s) in Company
1st Jun 20267:00 amRNSTransaction in Own Shares
29th May 20265:37 pmRNSTotal Voting Rights
26th May 20267:00 amRNSTransaction in Own Shares
21st May 20265:15 pmRNSDirector/PDMR Shareholding
19th May 202610:00 amRNSDirector Declaration
18th May 20267:00 amRNSTransaction in Own Shares
15th May 202611:45 amRNSResult of AGM
12th May 20267:00 amRNSTrading Statement
1st May 202610:30 amRNSHolding(s) in Company
30th Apr 20264:45 pmRNSTotal Voting Rights
22nd Apr 20265:00 pmRNSHolding(s) in Company
22nd Apr 202610:15 amRNSHolding(s) in Company
20th Apr 202610:30 amRNSHolding(s) in Company
14th Apr 202611:14 amRNSAnnual Financial Report
10th Apr 20264:45 pmRNSAdmission to Trading
7th Apr 20265:12 pmRNSEmployee Benefit Trust (“EBT”)
7th Apr 20264:45 pmRNSDirector/PDMR Shareholding
2nd Apr 20267:00 amRNSAppointment of Barclays as joint corporate broker
1st Apr 20267:00 amRNSDisposal of Horseferry House SW1
31st Mar 20264:45 pmRNSTotal Voting Rights
27th Mar 202612:45 pmRNSDirector/PDMR Shareholding
24th Mar 202610:30 amRNSDirector/PDMR Shareholding
20th Mar 20264:15 pmRNSDirector/PDMR Shareholding
16th Mar 20267:00 amRNSNetwork building fully pre-let
16th Mar 20267:00 amRNSNetwork building fully pre-let
27th Feb 20264:45 pmRNSTotal Voting Rights
26th Feb 20267:32 amRNSDerwent London plc Disposal of 90 Whitfield Street
26th Feb 20267:00 amRNSResults for the Year Ended 31 December 2025
6th Feb 20264:40 pmRNSHolding(s) in Company
6th Feb 20267:00 amRNSDisposal of 80-85 Tottenham Court Road W1
30th Jan 20264:45 pmRNSTotal Voting Rights
22nd Jan 20269:00 amRNSDirectorate change
15th Jan 202611:00 amRNSHolding(s) in Company
31st Dec 20251:15 pmRNSTotal Voting Rights
31st Dec 20251:15 pmRNSTotal Voting Rights
17th Dec 20257:00 amRNSPlanning success at Blue Star House SW9
9th Dec 20257:00 amRNSBurberry extends commitment to Horseferry House
28th Nov 20254:45 pmRNSTotal Voting Rights
6th Nov 20257:00 amRNSThird Quarter Business Update
31st Oct 20254:45 pmRNSTotal Voting Rights
21st Oct 20257:00 amRNSStrategic partnership at Old Street Quarter
9th Oct 20257:00 amRNSSuccessful completion of 25 Baker Street
30th Sep 20254:45 pmRNSTotal Voting Rights
30th Sep 202511:00 amRNSHolding(s) in Company
22nd Sep 202512:00 pmRNSBlock listing Interim Review
9th Sep 202511:45 amRNSDirector Declaration
2nd Sep 202511:30 amRNSHolding(s) in Company
29th Aug 20254:45 pmRNSTotal Voting Rights
12th Aug 20257:00 amRNSBoard Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.